seed
Stage
1
Investors
About
Cellivate Technologies develops an animal-free, extracellular vesicle-based alternative to fetal bovine serum (FBS) for cell culture, improving cell growth consistency and sustainability in biotech applications.
Explore Cellivate Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.